The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

SGLT2 diabetes meds like Jardiance or Farxiga do the same ... Both are risk factors for heart attack and stroke. “Another ...

A recent case report highlights the importance of understanding the possibility of the development of Euglycemic diabetic ...

The finance guru has warned that people who have £10,000 in savings could face losing money to tax, due to lucrative interest rates that are currently on the market.

Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ETCompany ParticipantsBill Szablewski - Head of Capital ...

Empagliflozin, or Empa, is a medication often used to help people with type 2 diabetes manage their blood sugar. Now, ...

It is notable, though, that FINEARTS-HF included patients (around 14%) who were already on SGLT2 drugs ... (hyperkalaemia), but that reflects its mechanism of action and hospitalisation rates ...

The choice of medication depends on the specific pathophysiological mechanism and the patient's overall health ... Hepprich et al. showed that SGLT2-inhibitors and IL-1 antagonism may improve PPH ...